
# ü©∫ Multimodal Pancreatic Cancer Detection (CT + Urine Biomarkers)

> **Dual-branch deep learning pipeline** combining CT scan ROI detection and urine biomarker analysis to aid early pancreatic cancer diagnosis.  
> Evaluates **multiple multimodal fusion strategies** (Late, Early, Orthogonal) on synthetic paired datasets to inform future clinical applications.

---

## üìå Table of Contents
- [Overview](#-overview)
- [Architecture](#-architecture)
- [Data Sources](#-data-sources)
- [Methodology](#-methodology)
- [Results](#-results)
- [Visualizations](#-visualizations)
- [Limitations & Future Work](#-limitations--future-work)
- [Installation](#-installation)
- [Usage](#-usage)
- [Project Structure](#-project-structure)
- [Citations](#-citations)
- [License](#-license)

---

## üöÄ Overview
This project explores **multimodal fusion** of:
1. **CT Imaging** ‚Äî Processed with **YOLOv8** to detect regions of interest (ROI) and **CNN** for classification.
2. **Urine Biomarkers** ‚Äî Modeled via a **Multi-Layer Perceptron (MLP)**.

The pipeline tests multiple **fusion strategies** using **synthetic pairing** of urine and CT data due to the unavailability of real paired datasets.

**Why it matters:**  
Pancreatic cancer often goes undetected until late stages. Combining imaging with biomarker data could improve early diagnosis ‚Äî our results provide insight into which fusion strategies may perform best when paired datasets become available.

---

## üèó Architecture
![Pipeline Diagram](docs/thesis_plan_update.png) <!-- Replace with actual pipeline diagram -->

**Steps:**
1. **Data Preprocessing**
   - CT DICOM ‚Üí PNG ‚Üí ROI extraction with YOLO
   - Urine biomarker cleaning & normalization
2. **Unimodal Training**
   - CT ROI ‚Üí CNN classifier
   - Urine biomarkers ‚Üí MLP classifier
3. **Fusion**
   - Late Fusion (logit averaging)
   - Early Fusion (feature concatenation)
   - Orthogonal Fusion (modality-specific projection layers)
4. **Evaluation**
   - Compare strategies on synthetic paired dataset
5. **Visualization**
   - Grad-CAM for CT slices
   - SHAP plots for urine features

---

## üìä Data Sources
- **CT Imaging**: NCI Pancreatic CT dataset ([TCIA](https://www.cancerimagingarchive.net/))
- **Urine Biomarkers**: Kaggle ‚Äî Early Pancreatic Cancer Urinary Biomarker Dataset ([Link](https://www.kaggle.com/))
- Synthetic pairing generated for fusion experiments.

---

## üî¨ Methodology
### **1. CT Imaging Branch**
- ROI detection with **YOLOv8** trained on annotated CT scans.
- Classification with **ResNet50** fine-tuned for pancreatic tumor detection.

### **2. Urine Biomarker Branch**
- Preprocessing: Missing value imputation, z-score normalization.
- Classification with **MLP** (2‚Äì3 dense layers + dropout).

### **3. Fusion Strategies**
- **Late Fusion**: Combine final prediction logits from both models.
- **Early Fusion**: Concatenate penultimate layer embeddings.
- **Orthogonal Fusion**: Learn modality-specific projections before fusion.

---

## üìà Results
| Modality      | Model         | Accuracy | Sensitivity | Specificity |
|---------------|--------------|----------|-------------|-------------|
| CT only       | ResNet50      | `<X.XX>` | `<X.XX>`    | `<X.XX>`    |
| Urine only    | MLP           | `<X.XX>` | `<X.XX>`    | `<X.XX>`    |
| Fusion (Late) | MLP + CNN     | `<X.XX>` | `<X.XX>`    | `<X.XX>`    |
| Fusion (Early)| MLP + CNN     | `<X.XX>` | `<X.XX>`    | `<X.XX>`    |
| Fusion (Orth) | MLP + CNN     | `<X.XX>` | `<X.XX>`    | `<X.XX>`    |

---

## üé® Visualizations
### **CT Grad-CAM**
![GradCAM Example](docs/gradcam_example.png)

### **Urine Biomarker SHAP**
![SHAP Example](docs/shap_example.png)

---

## ‚ö† Limitations & Future Work
- **Limitations**:
  - No real paired dataset for urine + CT
  - Fusion tested on synthetic pairing
- **Future Work**:
  - Apply on real paired datasets
  - Incorporate blood biomarkers
  - Deploy in a clinical decision-support setting

---

## üìÑ Documentation
- [ADR-001: Scope Change & Fusion Strategy Decisions](architectural_decision_records/ADR-001.md)

